Sofinnova Crossover I SLP 13D/13G Filings for ABIVAX SA (ABVX)

Sofinnova Crossover I SLP 13D and 13G filings for ABIVAX SA:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
4:19 pm
Purchase		 2025-02-14 13D ABIVAX SA
ABVX		 Sofinnova Crossover I SLP 7,794,478
11.000%		 845,865increase
(+12.17%)		 Filing
2023-10-30
1:42 pm
Purchase		 2023-10-20 13D ABIVAX SA
ABVX		 Sofinnova Crossover I SLP 6,948,613
8.000%		 6,948,613increase
(New Position)		 Filing